CINECA IRIS Institutional Research Information System

TALIANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.646
AS - Asia 8.261
EU - Europa 8.136
SA - Sud America 1.168
AF - Africa 425
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 2
Totale 34.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.063
IT - Italia 3.403
SG - Singapore 2.541
CN - Cina 2.518
HK - Hong Kong 1.339
SE - Svezia 1.232
BR - Brasile 986
DE - Germania 879
BG - Bulgaria 550
CA - Canada 461
VN - Vietnam 450
TR - Turchia 420
GB - Regno Unito 415
AT - Austria 316
RU - Federazione Russa 305
FI - Finlandia 266
IN - India 218
UA - Ucraina 204
KR - Corea 188
FR - Francia 174
JP - Giappone 153
CI - Costa d'Avorio 103
NG - Nigeria 85
BD - Bangladesh 72
MX - Messico 66
NL - Olanda 64
AU - Australia 63
CH - Svizzera 63
SN - Senegal 62
IQ - Iraq 61
AR - Argentina 58
BE - Belgio 56
PL - Polonia 54
ZA - Sudafrica 51
PK - Pakistan 41
ES - Italia 35
UZ - Uzbekistan 33
SA - Arabia Saudita 32
ID - Indonesia 31
EG - Egitto 29
VE - Venezuela 27
EC - Ecuador 26
KE - Kenya 24
CO - Colombia 22
CZ - Repubblica Ceca 20
JO - Giordania 19
MA - Marocco 17
AZ - Azerbaigian 16
IE - Irlanda 16
LT - Lituania 15
MY - Malesia 14
PY - Paraguay 14
DZ - Algeria 13
OM - Oman 13
AE - Emirati Arabi Uniti 12
PE - Perù 12
IR - Iran 11
JM - Giamaica 11
TT - Trinidad e Tobago 11
KZ - Kazakistan 10
TW - Taiwan 10
AL - Albania 9
CL - Cile 9
PT - Portogallo 9
GR - Grecia 8
LB - Libano 8
BJ - Benin 7
ET - Etiopia 7
IL - Israele 7
DK - Danimarca 6
PA - Panama 6
PS - Palestinian Territory 6
UY - Uruguay 6
BF - Burkina Faso 5
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GE - Georgia 5
HU - Ungheria 5
RO - Romania 5
BN - Brunei Darussalam 4
CR - Costa Rica 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PR - Porto Rico 4
QA - Qatar 4
TN - Tunisia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
SO - Somalia 3
ZM - Zambia 3
CG - Congo 2
CY - Cipro 2
GA - Gabon 2
GD - Grenada 2
GY - Guiana 2
Totale 34.660
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.761
Ashburn 1.636
Ann Arbor 1.492
Singapore 1.360
Hong Kong 1.323
Houston 1.318
Serra 1.185
Fairfield 1.039
Chandler 1.030
Santa Clara 929
Dallas 850
Milan 639
Sofia 550
Shanghai 529
Beijing 510
Seattle 424
New York 423
Wilmington 397
Ottawa 376
Cambridge 326
Los Angeles 296
Boardman 292
Izmir 281
Vienna 265
Princeton 264
Hefei 251
Jacksonville 249
Lawrence 220
Nanjing 177
Seoul 177
Medford 175
Frankfurt am Main 172
London 166
Des Moines 152
Dong Ket 147
Rho 129
Pisa 124
Istanbul 104
Abidjan 103
Redondo Beach 103
Dearborn 102
Rome 99
Munich 90
Buffalo 84
Lagos 83
Tokyo 79
Council Bluffs 77
São Paulo 77
Bremen 75
Florence 69
Ho Chi Minh City 69
Chicago 63
Dakar 62
Nanchang 60
Turku 60
San Diego 56
Brussels 55
Bern 54
The Dalles 50
Redwood City 49
San Jose 49
Boulder 48
Ogden 48
Kunming 45
Warsaw 44
Düsseldorf 43
Jüchen 41
Sydney 41
Columbus 40
Pune 40
Changsha 38
Fuzhou 38
Lucca 38
Shenyang 38
Hanoi 36
Hebei 35
San Francisco 34
Belo Horizonte 31
Livorno 31
Tashkent 31
Tianjin 31
Helsinki 30
Toronto 30
Johannesburg 29
Paris 29
Guangzhou 27
Nürnberg 27
Nuremberg 26
Quanzhou 26
Rio de Janeiro 26
Pistoia 24
Alessandria 23
Dhaka 23
Hangzhou 23
Norwalk 23
Brasília 22
Falls Church 22
Montreal 22
Phoenix 22
Stockholm 22
Totale 24.653
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 383
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 319
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 271
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 266
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 260
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 257
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 248
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 233
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 223
Allosteric modulators of human A2B adenosine receptor. 221
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 219
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 216
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 214
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 212
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 211
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 211
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 209
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 205
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 205
An update into the medicinal chemistry of translocator protein (TSPO) ligands 201
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 198
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 198
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 198
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 197
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 196
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 193
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 192
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 191
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 189
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 189
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 189
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 186
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 186
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 185
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 184
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 183
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 183
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 183
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 183
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 182
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 182
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 182
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 181
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 180
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 179
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 178
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 178
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 177
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 175
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 174
Metformin conjugates and therapeutic use thereof 173
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 173
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 172
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 172
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 172
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 171
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 171
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 169
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 169
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 169
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 168
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 168
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 165
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 164
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 163
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 162
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 162
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 161
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 161
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 160
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 160
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 159
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 158
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 157
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 157
Translocator protein ligands as promising therapeutic tools for anxiety disorders 157
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 156
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 155
Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein 155
New fluorescent probes for the pheripheral-type benzodiazepine receptor: synthesis and biological application 154
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 154
A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells 153
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 153
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists 153
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 153
The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein 151
Nuovi derivati acidi acetici quali potenti inibitori dell’Aldoso Reduttasi 151
Synthesis and Biological Evaluation of Pyrido[1,2-d]pyrimidin-4-one Derivatives as Novel Aldose Reductase Inhibitors Exhibiting Antioxidant Activity 151
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 151
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 151
Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO) 151
Naphtho[1,2-d]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors 150
Highlighting the new advances in drug discovery and development 150
Small Molecules Containing the Benzo[d]isotiazole Ring System as Novel ATP-Competitive Inhibitors of Epidermal Growth Factor Receptor protein Tyrosine Kinase 149
N,N-Dialkyl-2-phenylindol-3- ylglyoxylamides. A New Class of Potent and Selective Ligands at the Peripheral Benzodiazepine Receptor 149
Studies on enantioselectivity of chiral 4-acetylamino-6-alkyloxy-2-alkylthiopyrimidines acting as antagonists of the human A3 adenosine receptor 149
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 148
Modulation of PAR(1) signaling by benzimidazole compounds 148
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 148
Carbonic anhydrase activation profile of indole-based derivatives 148
Totale 18.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.118 0 0 0 0 0 74 62 162 231 137 115 337
2021/20222.662 79 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/20258.252 60 286 103 526 853 829 575 375 758 1.063 880 1.944
2025/20265.119 476 1.139 1.087 777 989 651 0 0 0 0 0 0
Totale 35.346